CYTOCAPS

Serial Number 75313456
606

Registration Progress

Application Filed
Jun 23, 1997
Under Examination
Sep 22, 1998
Approved for Publication
May 29, 1998
Published for Opposition
Jun 30, 1998
Registered

Trademark Image

CYTOCAPS

Basic Information

Serial Number
75313456
Filing Date
June 23, 1997
Published for Opposition
June 30, 1998
Abandonment Date
September 23, 2000
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 23, 2000
Classes
005

Rights Holder

QUADRANT HEALTHCARE (UK) LIMITED

03
Address
1 MERE WAY, RUDDINGTON
NOTTINGHAM NG116JS

Ownership History

Andaris Limited

Original Applicant
03
Ruddington, Nottingham

Andaris Limited

Owner at Publication
03
Ruddington, Nottingham

QUADRANT HEALTHCARE (UK) LIMITED

New Owner After Publication #1
03
NOTTINGHAM

Legal Representation

Attorney
H MATHEWS GARLAND

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Apr 5, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 17, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 26, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 26, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 20, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 6, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 22, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 22, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 30, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 29, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Apr 21, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 16, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 28, 1998 CNRT F NON-FINAL ACTION MAILED Loading...
Jan 27, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceuticals for treatment of cancers, malignant diseases, and tumors; microspheres incorporating cytotoxic agents for treatment of cancers, malignant diseases, and tumors
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
CYTO CAPS

Classification

International Classes
005